Deka Bank Deutsche Girozentrale Intellia Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$54.1 Billion
Q4 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 75,000 shares of NTLA stock, worth $652,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,000

Previous 75,000 -0.0%

Holding current value

$652,500

Previous $1.54 Million 44.05%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$23.82 - $32.8 $74,532 - $102,631	-3,129 Reduced 4.0%	75,000 $1.99 Million
Q4 2023 Jan 24, 2024	BUY	$23.16 - $32.34 $579,000 - $808,500	25,000 Added 47.06%	78,129 $2.5 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $98,938 - $143,245	3,129 Added 6.26%	53,129 $1.68 Million
Q1 2023 Apr 24, 2023	BUY	$33.3 - $44.82 $333,000 - $448,200	10,000 Added 25.0%	50,000 $1.77 Million
Q3 2022 Nov 02, 2022	BUY	$53.92 - $71.7 $377,440 - $501,900	7,000 Added 21.21%	40,000 $2.18 Million
Q2 2022 Aug 03, 2022	BUY	$38.49 - $76.21 $50,037 - $99,072	1,300 Added 4.1%	33,000 $1.7 Million
Q1 2022 Apr 28, 2022	BUY	$58.27 - $118.99 $384,582 - $785,334	6,600 Added 26.29%	31,700 $2.29 Million
Q4 2021 Feb 02, 2022	BUY	$100.76 - $138.36 $60,456 - $83,016	600 Added 2.45%	25,100 $2.94 Million
Q2 2021 Aug 05, 2021	SELL	$60.88 - $161.91 $121,760 - $323,820	-2,000 Reduced 7.55%	24,500 $3.91 Million
Q1 2021 Apr 28, 2021	BUY	$46.59 - $83.68 $358,743 - $644,336	7,700 Added 40.96%	26,500 $1.95 Million
Q4 2020 Mar 12, 2021	BUY	$18.83 - $63.53 $58,372 - $196,943	3,100 Added 19.75%	18,800 $1.02 Million
Q3 2020 Oct 29, 2020	BUY	$17.47 - $24.93 $274,279 - $391,401	15,700 New	15,700 $335,000
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $426,082 - $603,426	-32,600 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$13.88 - $18.41 $174,888 - $231,966	12,600 Added 63.0%	32,600 $496,000
Q1 2019 May 10, 2019	BUY	$12.79 - $17.62 $47,323 - $65,194	3,700 Added 22.7%	20,000 $624,000
Q4 2018 Feb 12, 2019	SELL	$11.39 - $27.13 $42,143 - $100,381	-3,700 Reduced 18.5%	16,300 $200,000
Q3 2018 Nov 09, 2018	SELL	$25.78 - $32.6 $348,030 - $440,100	-13,500 Reduced 40.3%	20,000 $0
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $60,060 - $92,370	3,000 Added 9.84%	33,500 $905,000
Q1 2018 May 03, 2018	BUY	$19.43 - $34.95 $503,237 - $905,205	25,900 Added 563.04%	30,500 $645,000
Q3 2017 Nov 06, 2017	BUY	$15.16 - $25.75 $69,736 - $118,450	4,600	4,600 $76,000

Others Institutions Holding NTLA

# of Institutions

336

Shares Held

96.1M

Call Options Held

1.06M

Put Options Held

863K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $661M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Intellia Therapeutics, Inc. Transaction History